Coronary Revascularization Clinical Trial
The SYNTAX score (SS) has been recommended by clinical guideline and appropriate use criteria
for coronary revascularization (CR) to provide guidance on optimal treatment strategies for
patients with stable coronary artery diseases (CAD). However, discrepancy in SS between
angiographic core lab (ACL) and cardiologists has been found. Whether the misestimate will
lead to inappropriate CR and whether a SS intervention will improve CR appropriateness in
patients with stable CAD remain unknown.
Thus, our study aims at evaluating whether a real-time feedback from ACL rightafter the
angiographies will improve CR appropriateness. A before-and-after controlled trial was
designed. In the first period of time, stable CAD patients undergoing elective coronary
angiographies with at least one coronary lesion stenosis ≥ 50% from one Chinese cardiac
center will be continuously recruited as the control group. In the second period, eligible
patients will be recruited continuously and a real-time SS category feedback from ACL
rightafter the angiography will be given to the cardiologists. Appropriateness of treatment
strategies in two groups will be analyzed to determine whether a real-time SS feedback can
improve the treatment appropriateness. The appropriateness of treatment strategies will be
adjudicated by Chinese version appropriate use criteria for CR.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05284747 -
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
|
Phase 4 | |
| Completed |
NCT01190904 -
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
|
N/A | |
| Completed |
NCT03229941 -
Transfusion Trigger After Operations in High Cardiac Risk Patients
|
N/A | |
| Completed |
NCT02880605 -
Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization
|
||
| Active, not recruiting |
NCT02425345 -
Women's Health Initiative Strong and Healthy Study
|
N/A |